Discover 243 paid clinical trials in Lebanon, New Hampshire. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Lebanon has about 15,000 residents and hosts the only National Cancer Institute designated comprehensive cancer centre in New Hampshire. Cancer research leads, including lung, ovarian, melanoma, and sarcoma studies, much of it run through the National Cancer Institute and cooperative groups, with epilepsy and inflammatory bowel disease the most visible non cancer areas.
Filter
2
Filter results
Results: 243
DESTINY-Endometrial01: A Phase III Study of Trastuzumab Deruxtecan Plus Rilvegostomig or Pembrolizumab as First-Line Treatment of HER2-Expressing (IHC 3+/2+), Mismatch Repair Proficient (pMMR) Endometrial Cancer
for
Endometrial Cancer
Location: Lebanon NH, Boston MA, Providence RI, Montreal,
Sponsor: AstraZeneca
Sex: Female
Age: 18+
Code: NCT06989112
Phase 3, Recruiting
New
Transcranial Direct Current Stimulation and Modulation of Affect and Pain
for
We Are Not Studying a Disease or Condition
Location: Hanover NH
Sponsor: Trustees of Dartmouth College
Sex: All
Age: 18 - 55
Code: NCT06989749
Recruiting
The Warmth, Anticipation, Sensation, Aversion, and Body-part Imaging Study
for
Pain
Location: Hanover NH
Sponsor: Trustees of Dartmouth College
Sex: All
Age: 18+
Code: NCT04653064
Recruiting
Genetic Risk, Parental Feeding Practices, and Appetitive Traits in Early Life
for
Childhood Obesity
Location: Hanover NH
Sponsor: Trustees of Dartmouth College
Sex: All
Age: 2 - 6
Code: NCT06534541
Recruiting
Virtual Contexts for Affective Modulation
for
Pain Control, Anxiety, Memory
Location: Hanover NH
Sponsor: Trustees of Dartmouth College
Sex: All
Age: 18 - 55
Code: NCT06986122
Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
Neural Mechanisms of Interpersonal Expectations on Negative Affect
Location: Lebanon NH, Charlottesville VA, Birmingham AL
Sponsor: University of Virginia
Sex: All
Age: 7+
Code: NCT06595420
Recruiting
Testing a Mammography Decision Intervention in a Rural Setting
for
Breast Cancer
Location: Newport NH, New London NH, Keene NH
Sponsor: Dartmouth-Hitchcock Medical Center
Sex: Female
Age: 39 - 49
Code: NCT06522568
Recruiting
Comparing Combinations of Targeted Drugs for Advanced Non-Small Cell Lung Cancer That Has EGFR and MET Gene Changes (A Lung-MAP Treatment Trial)
for
Recurrent Lung Non-Small Cell Carcinoma,
Location: Berlin Corners VT, Concord NH, Manchester NH,
Sponsor: SWOG Cancer Research Network
Sex: All
Age: 18+
Code: NCT05642572
Phase 2, Recruiting
Clinical Data Registry of Amblyopia Patients on Luminopia Treatment
for
Amblyopia
Location: Concord NH, Philadelphia PA, Indianapolis IN,
Sponsor: Luminopia
Sex: All
Age: 0+
Code: NCT06429280
Recruiting
Longitudinal Screening for Financial Hardship to Improve Outcomes in Patients With Advanced Cancer
for
Advanced Cancer, Metastatic Cancer
Location: Concord NH, Manchester NH, New York NY, Spartanburg SC,
Sponsor: Alliance Foundation Trials, LLC.
Sex: All
Age: 21+
Code: NCT06963723
Recruiting
Targeted Treatment for Advanced Non-Small Cell Lung Cancer That Has a MET Exon 14 Skipping Gene Change (An Expanded Lung-MAP Treatment Trial)
for
Recurrent Lung Non-Small Cell Carcinoma,
Location: Concord NH, Manchester NH, Burlington MA, Worcester MA,
Sponsor: SWOG Cancer Research Network
Sex: All
Age: 0+
Code: NCT06031688
Phase 2, Recruiting
TAPUR: Testing the Use of Food and Drug Administration (FDA) Approved Drugs That Target a Specific Abnormality in a Tumor Gene in People With Advanced Stage Cancer
Location: Concord NH, Manchester NH, Sanford ME, Portsmouth NH,
Sponsor: American Society of Clinical Oncology
Sex: All
Age: 12+
Code: NCT02693535
Phase 2, Recruiting
Targeted Treatment for Advanced Non-Small Cell Lung Cancer That Has Increased Copies of the MET Gene (An Expanded Lung-MAP Treatment Trial)
for
Lung Non-Small Cell Carcinoma
Location: Concord NH, Manchester NH, Burlington MA, Worcester MA,
Sponsor: SWOG Cancer Research Network
Sex: All
Age: 18+
Code: NCT06116682
Phase 2, Recruiting
A Phase II Nationwide, Fully Decentralized, Telemedicine Study of Pemigatinib in Adult Patients With Advanced or Metastatic Pancreatic Cancer With FGFR Genetic Alterations